Amir F. Heshmatpour is the Executive Chairman and President of NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), where he drives the company’s mission to transform the treatment of brain cancers through breakthrough science and global partnerships. With over 25 years of executive and board leadership, Mr. Heshmatpour brings a proven track record of building companies, guiding capital markets strategies, and advancing life-changing innovations from concept to commercialization.

In 2005, he founded AFH Holding & Advisory LLC, his single-family office, through which he has led more than $6 billion in transactions across multiple industries, with a focus on biotech and healthcare. Since acquiring NeOnc in 2023 and assuming the presidency in 2025, Mr. Heshmatpour has been instrumental in strengthening the company’s global footprint, accelerating clinical programs, and securing cornerstone partnerships that expand patient access across the U.S., GCC/MENA, and India.

Beyond his corporate leadership, Mr. Heshmatpour is committed to education and philanthropy. He holds a certification in corporate governance from the UCLA Anderson School of Management, where he also serves as a Board Advisor to the Price Center for Entrepreneurship & Innovation. In 2024, he was appointed to the Board of Directors of Make-A-Wish Foundation (Tri-Counties, Los Angeles Chapter), reflecting his dedication to improving the lives of families facing critical health challenges.

A strategic visionary and passionate advocate for patients, Mr. Heshmatpour combines financial acumen, entrepreneurial drive, and global perspective to position NeOnc Technologies as a first-mover in the fight against brain cancer.